Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05424380
Title A Phase 1, Open Label Study of Intravenous GSK3745417 to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Determine RP2D & Schedule in Participants With Relapsed or Refractory Myeloid Malignancies Including AML and HR MDS
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors GlaxoSmithKline
Age Groups: senior | adult
Covered Countries NLD | ITA | ESP | DEU | CAN

No variant requirements are available.